EpigenCare (EPIC) ICO

updated 01 January 2018

Truly Personalized Skincare Based on Epigenetics

Whitepaper
Token sale info
LVL
Status: ended
Start: 19 March 2018
End: 30 July 2018
Cap: No info
Goal: No info
Find out more

EpigenCare

About EpigenCare

Scientifically Grounded

How does a consumer know whether a skincare product is truly working for them? EpigenCare is connecting consumers with skincare companies through a direct-to-consumer skincare test and web platform on the Ethereum network. Consumers will be able to receive actionable recommendations of optimized skincare products to use, as well as assess the progress of their skincare routines, based on their skin’s epigenetic profiles. The recommendation engine looks at the functional state of a panel of epigenetic markers strongly correlated with skin quality indicators (e.g., aging, moisture retention, elasticity, etc.), and how skincare product ingredients affect them.

 

A Cyclical Growth Ecosystem

As epigenetics regulates gene function and dynamically changes based on environment stimuli such as skincare product ingredients, it is a perfect fit for a recurring, tokenized business model. EpigenCare’s upcoming platform will be a structured ecosystem that allows skincare companies to target data segments with products that fulfill the recommendation engine’s matching requirements. Consumers that fall within the segment are rewarded with tokens, which can be used to subsidize additional tests (thereby generating additional advertising inventory for companies).

 

Disrupting the Skincare Industry

Our structured ecosystem allows for true leveraging of blockchain technology. The recurring nature of epigenetics allows for a perpetual incentivization model through data tokenization. By associating a transaction hash ID with each purchased test and data segment, we will be able to transparently prove that a consumer’s data is used only for their own benefit, thereby addressing the problem of perceived intrusiveness often associated with commercialized DNA-related testing. EpigenCare’s disruptive innovation introduces a new marketing channel to the $130 billion skincare industry and transform the way companies market their products to consumers through scientifically screened, individualized advertising.

 

Comments0